相关实验视频
Updated: Jul 29, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.7K
p53 在多克索鲁比诱导的心脏毒性和耐药性之间的十字路口:营养平衡行为
Yuanfang Guo1, Yufeng Tang2, Guangping Lu1
1School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Nutrients
|May 27, 2023
概括
多克索鲁比 (DOX) 化疗会引起心脏毒性和耐药性,通常与p53基因有关. 本综述探讨了针对p53的策略,以提高DOX的疗效,同时最大限度地减少副作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多克索鲁比 (DOX) 是一种重要的化疗剂,但会引起心脏毒性和耐药性.
- 瘤抑制基因p53在DOX的有效性,毒性和耐药性方面发挥着双重作用.
- p53突变或失活是DOX耐药性的关键机制.
研究的目的:
- 审查p53在DOX诱导的心脏毒性 (DIC) 和化学抵抗中的复杂作用.
- 探索针对p53的治疗策略,以克服DOX抗性和心脏毒性.
- 为改善DOX临床应用和抗癌益处提供见解.
主要方法:
- 文献综述侧重于p53在DOX治疗中的作用.
- 对饮食营养素,天然产品和药理干预措施的分析.
- 检查p53向疗法的挑战和进展.
主要成果:
- p53是DOX耐药性和心脏毒性的关键因素.
- 准p53具有复杂的挑战,因为它的双重作用.
- 饮食营养素,天然产品和药理学剂显示出有希望的结果.
结论:
- 调节p53提供了一个潜在的途径来提高DOX的有效性.
- 平衡p53的作用对于减轻心脏毒性和耐药性至关重要.
- 为了改善癌症治疗,需要对p53向策略进行进一步的研究.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Negative Regulator Molecules
35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K

